The Japanese government is planning an unprecedentedly short screening period of three weeks once Fujifilm Toyama Chemical Co submits a new drug application.
The news comes via the , citing unnamed sources.
Japan govmt planning to approve COVID-19 treatment drug Avigan in November
Tweet on Twitter
Share on Facebook
Google+
Pinterest